Pulmonary blastoma
diseaseOn this page
Also known as blastoma of lungblastoma of the lunglung blastomaPneumoblastoma
Summary
Pulmonary blastoma (MONDO:0005933) is a disease and 1 clinical trial. A subtype of blastoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 9
- Clinical trials: 1
Clinical features
Epidemiology
Prevalence records
8 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 350 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated | |
| Annual incidence | <1 / 1 000 000 | Europe | Validated | |
| Annual incidence | <1 / 1 000 000 | 0.002 | Belgium | Validated |
| Annual incidence | <1 / 1 000 000 | 0.005 | Finland | Validated |
| Annual incidence | <1 / 1 000 000 | 0.001 | Germany | Validated |
| Annual incidence | <1 / 1 000 000 | 0.002 | Italy | Validated |
| Annual incidence | <1 / 1 000 000 | 0.002 | Netherlands | Validated |
Signs & symptoms
Clinical features (HPO)
9 HPO clinical features (Orphanet curated; top 9 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0002105 | Hemoptysis | Very frequent (80-99%) |
| HP:0002113 | Pulmonary infiltrates | Very frequent (80-99%) |
| HP:0012735 | Cough | Very frequent (80-99%) |
| HP:0100528 | Pleuropulmonary blastoma | Very frequent (80-99%) |
| HP:0100749 | Chest pain | Very frequent (80-99%) |
| HP:0001824 | Weight loss | Frequent (30-79%) |
| HP:0001945 | Fever | Frequent (30-79%) |
| HP:0002094 | Dyspnea | Frequent (30-79%) |
| HP:0006532 | Recurrent pneumonia | Frequent (30-79%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | pulmonary blastoma |
| Mondo ID | MONDO:0005933 |
| EFO | EFO:0007458 |
| MeSH | D018202 |
| Orphanet | 64741 |
| DOID | DOID:4765 |
| NCIT | C3732 |
| SNOMED CT | 189815007 |
| UMLS | C0206629 |
| MedGen | 61645 |
| GARD | 0018864 |
| Anatomy (UBERON) | UBERON:0002048 |
| Is cancer (heuristic) | no |
Also known as: blastoma of lung · blastoma of the lung · lung blastoma · Pneumoblastoma · pulmonary blastoma
Data availability: 2 cell lines.
Disease family
An umbrella term covering 3 Mondo subtypes.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › blastoma › pulmonary blastoma
Related subtypes (2): gonadoblastoma, pituitary blastoma
Subtypes (3): classic pulmonary blastoma, epithelial predominant pulmonary blastoma, pleuropulmonary blastoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT07005297 | Not specified | NOT_YET_RECRUITING | Clinical Genetics Branch Eligibility Screening Survey |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.